Thompson Siegel & Walmsley’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$501K	Sell	86,320 -14,564	-14%	-$96.6K	0.01%	358
2025 Q4	$792K	Hold	100,884	–	–	0.01%	325
2025 Q3	$821K	Sell	100,884 -165,503	-62%	-$1.1M	0.01%	324
2025 Q2	$1.24M	Buy	266,387 +93,603	+54%	+$429K	0.02%	291
2025 Q1	$949K	Buy	172,784 +20,000	+13%	+$80.7K	0.02%	288
2024 Q4	$518K	Sell	152,784 -20,000	-12%	-$64.3K	0.01%	316
2024 Q3	$492K	Hold	172,784	–	–	0.01%	323
2024 Q2	$389K	Sell	172,784 -17,216	-9%	-$34.7K	0.01%	315
2024 Q1	$420K	Buy	+190,000	New	+$492K	0.01%	307
2021 Q3	–	Sell	-62,000	Closed	-$252K	–	749
2021 Q2	$252K	Buy	62,000 +17,000	+38%	+$64.9K	﹤0.01%	354
2021 Q1	$203K	Buy	45,000 +43,750	+3,500%	+$236K	﹤0.01%	353
2020 Q4	$6K	Buy	+1,250	New	+$6.25K	﹤0.01%	631